Fundraising FoxSirnaMed Therapeutics
Sewickley, US · Founded 2023 · Delaware corporation
Find your way into SirnaMed Therapeutics
54 people in our graph can introduce you to the SirnaMed Therapeutics team.
Sign up to see every warm intro you have to SirnaMed Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SirnaMed Therapeutics team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
PT
Phong TranExecutivePhong Tran has held leadership roles across pharmaceutical, biotech, and medical technology companies, including President and CEO of SirnaMed Therapeutics, Interim CEO at Bound Therapeutics, and senior research positions at Pfizer, Ionis Pharmaceuticals, and Regulus Therapeutics. He previously served in the U.S. Navy as a Preventive Medicine Officer and has contributed to multiple FDA drug approvals and investigational new drug applications.
JH
Jing-Zhou HouNamed on SEC filing
SL
Song LiNamed on SEC filing
Board
SM
Stanley MarksBoard director
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 1 round · 2024
▶$1.3MraisedJul 2024 · 9 investors · PharmaceuticalsRule 506(b)
▶$1.3MraisedJul 2024 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Phong TranExecutive Officer
- Stanley MarksDirector
- Jing-Zhou HouExecutive Officer, Director, Promoter
- Song LiExecutive Officer, Director, Promoter
- Offering amount
- $1.5M
- Amount sold
- $1.3M
- Minimum investment
- $50K
- Proceeds to insiders
- $165K
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has SirnaMed Therapeutics raised?
- SirnaMed Therapeutics has disclosed $1.3M raised across 1 round.
- Where is SirnaMed Therapeutics headquartered?
- SirnaMed Therapeutics is headquartered in Sewickley, US.